Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters
Author:
Affiliation:
1. Department of Rheumatology, Immunology and Allergology, University Hospital and University of Bern, Bern, Switzerland
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Link
http://academic.oup.com/rheumatology/article-pdf/57/7/1235/25068708/key053.pdf
Reference29 articles.
1. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study;de Man;Arthritis Rheum,2008
2. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy;Barrett;Arthritis Rheum,1999
3. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis;Ostensen;Arthritis Rheum,1983
4. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments;Ostensen;Ann Rheum Dis,2004
5. Reduced pro-inflammatory profile of gammadeltaT cells in pregnant patients with rheumatoid arthritis;Tham;Arthritis Res Therapy,2016
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes;Reumatismo;2024-09-11
2. Causal Association of Rheumatoid Arthritis With Adverse Pregnancy Outcomes: Genetic Evidence From Mendelian Randomization;American Journal of Reproductive Immunology;2024-09
3. Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019;Pharmacoepidemiology and Drug Safety;2024-08
4. The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management;The Lancet Rheumatology;2024-08
5. Exposure to golimumab during pregnancy: Results from the Company's global safety database;Pharmacology Research & Perspectives;2024-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3